511 related articles for article (PubMed ID: 16982418)
1. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
[TBL] [Abstract][Full Text] [Related]
2. Inherited neuropathies: new genes don't fit old models.
Scherer SS
Neuron; 2006 Sep; 51(6):672-4. PubMed ID: 16982409
[TBL] [Abstract][Full Text] [Related]
3. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy.
Jordanova A; Irobi J; Thomas FP; Van Dijck P; Meerschaert K; Dewil M; Dierick I; Jacobs A; De Vriendt E; Guergueltcheva V; Rao CV; Tournev I; Gondim FA; D'Hooghe M; Van Gerwen V; Callaerts P; Van Den Bosch L; Timmermans JP; Robberecht W; Gettemans J; Thevelein JM; De Jonghe P; Kremensky I; Timmerman V
Nat Genet; 2006 Feb; 38(2):197-202. PubMed ID: 16429158
[TBL] [Abstract][Full Text] [Related]
4. The GARS gene is rarely mutated in Japanese patients with Charcot-Marie-Tooth neuropathy.
Abe A; Hayasaka K
J Hum Genet; 2009 May; 54(5):310-2. PubMed ID: 19329989
[TBL] [Abstract][Full Text] [Related]
5. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
[TBL] [Abstract][Full Text] [Related]
6. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
[TBL] [Abstract][Full Text] [Related]
7. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
[TBL] [Abstract][Full Text] [Related]
8. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
[TBL] [Abstract][Full Text] [Related]
9. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.
He W; Bai G; Zhou H; Wei N; White NM; Lauer J; Liu H; Shi Y; Dumitru CD; Lettieri K; Shubayev V; Jordanova A; Guergueltcheva V; Griffin PR; Burgess RW; Pfaff SL; Yang XL
Nature; 2015 Oct; 526(7575):710-4. PubMed ID: 26503042
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations.
Sivakumar K; Kyriakides T; Puls I; Nicholson GA; Funalot B; Antonellis A; Sambuughin N; Christodoulou K; Beggs JL; Zamba-Papanicolaou E; Ionasescu V; Dalakas MC; Green ED; Fischbeck KH; Goldfarb LG
Brain; 2005 Oct; 128(Pt 10):2304-14. PubMed ID: 16014653
[TBL] [Abstract][Full Text] [Related]
11. Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A.
Cartoni R; Arnaud E; Médard JJ; Poirot O; Courvoisier DS; Chrast R; Martinou JC
Brain; 2010 May; 133(Pt 5):1460-9. PubMed ID: 20418531
[TBL] [Abstract][Full Text] [Related]
12. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
[TBL] [Abstract][Full Text] [Related]
13. Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect.
Nangle LA; Zhang W; Xie W; Yang XL; Schimmel P
Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11239-44. PubMed ID: 17595294
[TBL] [Abstract][Full Text] [Related]
14. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
[TBL] [Abstract][Full Text] [Related]
15. Atrophy and degeneration in sciatic nerve of presymptomatic mice carrying the Huntington's disease mutation.
Wade A; Jacobs P; Morton AJ
Brain Res; 2008 Jan; 1188():61-8. PubMed ID: 18062944
[TBL] [Abstract][Full Text] [Related]
16. The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V.
Dubourg O; Azzedine H; Yaou RB; Pouget J; Barois A; Meininger V; Bouteiller D; Ruberg M; Brice A; LeGuern E
Neurology; 2006 Jun; 66(11):1721-6. PubMed ID: 16769947
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.
Sleigh JN; Grice SJ; Burgess RW; Talbot K; Cader MZ
Hum Mol Genet; 2014 May; 23(10):2639-50. PubMed ID: 24368416
[TBL] [Abstract][Full Text] [Related]
18. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.
Mo Z; Zhao X; Liu H; Hu Q; Chen XQ; Pham J; Wei N; Liu Z; Zhou J; Burgess RW; Pfaff SL; Caskey CT; Wu C; Bai G; Yang XL
Nat Commun; 2018 Mar; 9(1):1007. PubMed ID: 29520015
[TBL] [Abstract][Full Text] [Related]
19. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d.
Spaulding EL; Sleigh JN; Morelli KH; Pinter MJ; Burgess RW; Seburn KL
J Neurosci; 2016 Mar; 36(11):3254-67. PubMed ID: 26985035
[TBL] [Abstract][Full Text] [Related]
20. Functional analyses of glycyl-tRNA synthetase mutations suggest a key role for tRNA-charging enzymes in peripheral axons.
Antonellis A; Lee-Lin SQ; Wasterlain A; Leo P; Quezado M; Goldfarb LG; Myung K; Burgess S; Fischbeck KH; Green ED
J Neurosci; 2006 Oct; 26(41):10397-406. PubMed ID: 17035524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
